The Indian Pharma industry is known for its positive approach to changes which helps the industry to come out stronger from any challenges they face. The recent changes happening in the regulatory front would help the Indian pharma industry to move closer to the regulatory norms of advanced markets. Hence, the projected growth of the market is at CAGR of 8.4 percent. RN Pharma Consulting is one such pioneering consultancy firm that has been able to develop into one of the most reputed and well-established brands in the market owing to the quality and innovativeness of its services.
RN Pharma always works by knowing the upcoming plans of the sponsor company, preferably 5-10 years projections. They suggest strategies for manufacturing plant or product development projects that will satisfy the company's need over the projected horizon of 5-10 years, thereby cutting costs and timelines involved in restructuring, alterations, or multiple times product development efforts. The company’s USP is their expertise in the niche segment of Inhalation and Injectable formulations and manufacturing that largely satisfies the need of Indian and Overseas markets. Owing to this expertise, RN Pharma does many projects in Inhalation and Injectables, providing “end-to-end” consultancy to their sponsor companies. The company has an impressive track record when it comes to repeat clientele which showcases their quality.
While talking about what makes RN Pharma different from the rest of the competitors in the industry, Dr. Ravindra Purohit, Promoter, RN Pharma says, “We believe in competing with ourselves, so our efforts are always directed towards improving our services. This approach ensures that we end up being self-competitors. Our tagline is “We are the missing piece of your jigsaw puzzle”. We strive to live up to this expectation, so we do not restrict our services merely to the “You ask, I tell” approach. We proactively suggest to our sponsors about all possibilities in a project and actively strive to practice the accepted suggestions to benefit our sponsors in achieving the crucial timelines in optimum budgets. For us, the sponsor company’s needs and the possible resource allocation to the projects are critical.
Our primary motto is to provide “pro-active” consultancy that necessitates taking ownership of the project. We are also always happy to take ownership of the projects allocated to us. And we ensure adequate training to our sponsor company’s technical team in all aspects of product manufacturing and development. In a few niche areas such as Inhalation technology, we are amongst the very few in the country, so we need to ensure that we remain updated and pass on our expertise to the sponsors effectively”.
Dr Ravindra Purohit has 30 years plus experience in pMDIs, DPIs & Nasal Sprays Formulation and Medical Device & Device Material Development. With his excellent skills and knowledge in pMDIs, DPIs & Nasal Sprays Process Development and Projects for Commercial Manufacturing, Dr Ravindra Purohit has developed a plethora of products for OINDP markets in domestic, regulated and semi regulated
Elucidating more on their future plans, Dr. Ravindra Purohit, states that, “We have our firm work ethics, and in the long run, we would like to be known for our reliability, ethics, and integrity. We take pride in the fact that we do not compromise on our work ethics. After all, if we are “the missing piece of a jig-saw puzzle” of our clients, then we would want to be that piece of the puzzle that holds the entire picture together and make it meaningful. Over a period of the next 5 years, we envisage becoming a globally known consultancy firm. We also want to expand our services in Quality Assurance and Compliance areas, more specifically for the niche formulation areas such as Inhalation and Injectables. We would be striving to break the mould of generic product development and strive to work on newer technologies, new products, and repurposed drugs. We are already working on one New product and would like to take up some more challenges of this type shortly.
